Citation: | Han Wang, Ming-Wang Long, Li Zhang, Yue Pan, Jun-Ying Chen, Kai Feng, Qiang-Ming Sun. Establishment of a non-lethal model of antibody-dependent enhancement of infection in A129 mice based on a non-mouse-adapted dengue virus strain. Zoological Research, 2023, 44(5): 943-946. doi: 10.24272/j.issn.2095-8137.2023.002 |
[1] |
Guzman MG, Halstead SB, Artsob H, et al. 2010. Dengue: a continuing global threat. Nature Reviews Microbiology, 8(12): S7−S16.
|
[2] |
Kayesh MEH, Tsukiyama-Kohara K. 2022. Mammalian animal models for dengue virus infection: a recent overview.
|
[3] |
Malavige GN, Ogg GS. 2017. Pathogenesis of vascular leak in dengue virus infection.
|
[4] |
Pierson TC, Diamond MS. 2020. The continued threat of emerging flaviviruses.
|
[5] |
Sarathy VV, Infante E, Li L, et al. 2015. Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-α/β and IFN-γ receptors (AG129) and comparison with the DENV-2 AG129 mouse model.
|
[6] |
Shepard DS, Undurraga EA, Halasa YA, et al. 2016. The global economic burden of dengue: a systematic analysis.
|
[7] |
Tan GK, Ng JKW, Trasti SL, et al. 2010. A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice.
|
[8] |
Tsai TT, Chuang YJ, Lin YS, et al. 2013. An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection.
|
[9] |
WHO. 1997. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. Geneva: WHO.
|
[10] |
Zheng ZH, Li M, Liu ZH, et al. 2020. Establishment of murine infection models with biological clones of dengue viruses derived from a single clinical viral isolate.
|
![]() |
![]() |